> The FDA has issued its second approvable letter for Shire's ADHD drug Vyvanse. Report
> Galapagos has acquired ProSkelia, a French subsidiary of ProStrakan in a deal worth up to €45 million. Report
> Allergan has announced that the FDA has asked for more data on its eye pressure medication Combigan. Report
> The FDA has approved Novartis' Exforge for high blood pressure. Release
> Protiva Biotherapeutics has filed an appeal that seeks to overturn the BC Supreme Court's ruling that would permit Inex Pharmaceuticals Corporation to transfer the Inex-Protiva agreements to Tekmira Corporation without Protiva's consent. Release
And Finally... Drug reps will face a tough year in 2007. Report